Local Bounti Corporation/DE 8-K

What Happened

• Local Bounti Corporation (LOCL) announced on March 13, 2026 that it entered a Convertible Note and Warrant Purchase Agreement with U.S. Bounti, LLC. The agreement provides for a $15.0 million convertible note and a common stock purchase warrant for 5,500,000 shares. The company said proceeds will be used for working capital, general corporate purposes and certain capital expenditures.
• Key terms: the note bears 7.0% annual interest paid-in-kind (PIK) semi‑annually (interest increases principal), initial conversion price $2.50 per share (conversion of the $15M principal alone = 6,000,000 shares), and conversion features that include automatic conversion of 50% of the Note on the fourth anniversary and the remaining 50% at maturity (with a cash-pay option for the 50% conversions if conditions are met). The warrant is immediately exercisable at $0.125 per share and expires 10 years from initial exercise.
• The company also entered a letter agreement with Cargill Financial Services International, Inc. to amend its Senior Credit Agreement: minimum liquidity covenant set to $3.5M through Sept. 30, 2026 and $2.0M thereafter, EBITDA covenant testing delayed to March 31, 2027, and Cargill consented to the Note and Warrant issuance. The company must seek required NYSE stockholder approval (removing a 1% issuance cap) no later than June 30, 2026.

Key Details

• Note principal: $15.0 million; interest: 7.0% per year, PIK semi‑annually (dec. 31 and June 30), cash interest payment possible after the 3rd anniversary if conditions met.
• Initial conversion price: $2.50/share → $15M converts to 6,000,000 shares (plus additional shares if PIK interest is added to principal).
• Warrant: right to purchase 5,500,000 shares; exercise price $0.125/share; 10‑year term; exercisable immediately.
• Stockholder approval: issuance limits restrict Purchaser to 1% of outstanding common stock until Required Stockholder Approval is obtained (company must seek approval by June 30, 2026).
• Credit amendment: liquidity covenant revised to $3.5M (through 9/30/26) then $2.0M; EBITDA test delayed to 3/31/27; Cargill consented.

Why It Matters

• Liquidity and runway: the $15M infusion provides immediate cash for working capital and planned capital spending, reducing near‑term funding pressure.
• Potential dilution: conversion of the $15M note (6.0M shares) plus exercise of the 5.5M-share warrant could add up to ~11.5M shares to the equity base (more if PIK interest increases principal). However, issuance is limited until shareholder approval is obtained, which the company must pursue by June 30, 2026.
• Credit and covenant relief: the Cargill amendment eases near‑term liquidity and covenant timing, which may reduce the risk of covenant breaches in the short term; note, the new note is subordinated to the senior credit facility.
• Investor takeaway: this filing signals a capital raise that improves near‑term liquidity but introduces potential dilution and increased indebtedness (via PIK interest). Retail investors should watch for the shareholder vote, any registration of securities, and future disclosure on actual conversions or warrant exercises.